These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 37751191
1. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers. Riedinger CJ, Esnakula A, Haight PJ, Suarez AA, Chen W, Gillespie J, Villacres A, Chassen A, Cohn DE, Goodfellow PJ, Cosgrove CM. Cancer; 2024 Feb 01; 130(3):385-399. PubMed ID: 37751191 [Abstract] [Full Text] [Related]
2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma]. Liu Y, Wang YX, Sun XJ, Ting X, Wu R, Liu XD, Liu CR. Zhonghua Fu Chan Ke Za Zhi; 2023 Oct 25; 58(10):755-765. PubMed ID: 37849256 [Abstract] [Full Text] [Related]
4. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D. J Clin Oncol; 2015 Dec 20; 33(36):4301-8. PubMed ID: 26552419 [Abstract] [Full Text] [Related]
5. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, Church DN, Morreau H, Smit VTHBM, van Wezel T, Bosse T. Ann Oncol; 2017 Jan 01; 28(1):96-102. PubMed ID: 27742654 [Abstract] [Full Text] [Related]
6. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH, Wu HW, Wang J, Liang ZY. Zhonghua Bing Li Xue Za Zhi; 2021 May 08; 50(5):470-475. PubMed ID: 33915653 [Abstract] [Full Text] [Related]
7. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM. Am J Surg Pathol; 2014 Jun 08; 38(6):793-800. PubMed ID: 24503759 [Abstract] [Full Text] [Related]
8. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. Timmerman S, Van Rompuy AS, Van Gorp T, Vanden Bempt I, Brems H, Van Nieuwenhuysen E, Han SN, Neven P, Victoor J, Laenen A, Vergote I. Gynecol Oncol; 2020 Apr 08; 157(1):245-251. PubMed ID: 31980219 [Abstract] [Full Text] [Related]
9. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Smithgall MC, Remotti H, Hsiao SJ, Mansukhani M, Liu-Jarin X, Fernandes H. Hum Pathol; 2022 Jan 08; 119():41-50. PubMed ID: 34666078 [Abstract] [Full Text] [Related]
10. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, Pritchard CC. Gastroenterology; 2014 Dec 08; 147(6):1308-1316.e1. PubMed ID: 25194673 [Abstract] [Full Text] [Related]
11. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Hampel H, Pearlman R, de la Chapelle A, Pritchard CC, Zhao W, Jones D, Yilmaz A, Chen W, Frankel WL, Suarez AA, Cosgrove C, Backes F, Copeland L, Fowler J, O'Malley D, Salani R, McElroy JP, Stanich PP, Goodfellow P, Cohn DE. Gynecol Oncol; 2021 Jan 08; 160(1):161-168. PubMed ID: 33393477 [Abstract] [Full Text] [Related]
12. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM, Gordhandas S, Maddy BP, Baltich Nelson B, Askin G, Christos PJ, Caputo TA, Chapman-Davis E, Holcomb K, Frey MK. Cancer; 2019 Sep 15; 125(18):3172-3183. PubMed ID: 31150123 [Abstract] [Full Text] [Related]
13. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM, Sloan EA, Thomas M, Modesitt SC, Stoler MH, Atkins KA, Moskaluk CA. Am J Surg Pathol; 2016 Feb 15; 40(2):155-65. PubMed ID: 26523542 [Abstract] [Full Text] [Related]
14. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Chao X, Li L, Wu M, Ma S, Tan X, Zhong S, Bi Y, Lang J. Cancer Commun (Lond); 2019 Jul 15; 39(1):42. PubMed ID: 31307542 [Abstract] [Full Text] [Related]
15. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F, Crook A, Maidens J, McEvoy C, Fellowes A, Pickett J, Ho M, Nevell D, McIlroy K, Sheen A, Sioson L, Ahadi M, Turchini J, Clarkson A, Hogg R, Valmadre S, Gard G, Dooley SJ, Scott RJ, Fox SB, Field M, Gill AJ. Pathology; 2017 Aug 15; 49(5):457-464. PubMed ID: 28669579 [Abstract] [Full Text] [Related]
16. Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome. Liu YL, Cadoo KA, Maio A, Patel Z, Kemel Y, Salo-Mullen E, Catchings A, Ranganathan M, Kane S, Soslow R, Ceyhan-Birsoy O, Mandelker D, Carlo MI, Walsh MF, Shia J, Markowitz AJ, Offit K, Stadler ZK, Latham A. Genet Med; 2022 Jun 15; 24(6):1187-1195. PubMed ID: 35346574 [Abstract] [Full Text] [Related]
17. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers. Evans DG, Lalloo F, Ryan NA, Bowers N, Green K, Woodward ER, Clancy T, Bolton J, McVey RJ, Wallace AJ, Newton K, Hill J, McMahon R, Crosbie EJ. J Med Genet; 2022 Apr 15; 59(4):328-334. PubMed ID: 33452216 [Abstract] [Full Text] [Related]
18. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation. Kaya M, Post CCB, Tops CM, Nielsen M, Crosbie EJ, Leary A, Mileshkin LR, Han K, Bessette P, de Boer SM, Jürgenliemk-Schulz IM, Lutgens L, Jobsen JJ, Haverkort MAD, Nout RA, Kroep J, Creutzberg CL, Smit VTHBM, Horeweg N, van Wezel T, Bosse T. Mod Pathol; 2024 Mar 15; 37(3):100423. PubMed ID: 38191122 [Abstract] [Full Text] [Related]
19. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ. Hum Pathol; 2017 Dec 15; 70():121-128. PubMed ID: 29107668 [Abstract] [Full Text] [Related]
20. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y, Guo YH, Luo Y, Sun L, Zhao S, Shao B, Zang FL, Qiu ZQ, Sun BC, Sun Y. Zhonghua Bing Li Xue Za Zhi; 2021 Apr 08; 50(4):369-375. PubMed ID: 33831997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]